Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Comparing two ways to give antibiotics during ankle surgery

Official title: Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty

Run by The Methodist Hospital Research Institute · NCT06384651 · Data updated 2026-11-12

This study is testing whether giving antibiotics directly into the bone or through an IV during ankle surgery works equally well to prevent infections after the operation.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorThe Methodist Hospital Research Institute
Academic / other
Drugs / interventionsradiation
Locations1 site (Houston, Texas)
StatusRecruiting
StartedDecember 3, 2024
Main results expectedApril 2027
Study endsDecember 2027
Registry record updatedJanuary 24, 2025
Trial IDNCT06384651 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who are scheduled for total ankle arthroplasty and can provide informed consent.

Probably not a fit

Patients with previous lower extremity surgeries, high BMI, or contraindications to vancomycin will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares intraosseous and intravenous administration of vancomycin in patients undergoing total ankle arthroplasty. The primary objective is to determine if both methods achieve comparable levels of the antibiotic in bone, soft tissue, and systemic samples. Additionally, the study will assess the rates of post-operative complications, specifically infections, at 30 and 90 days after surgery. The hypothesis is that there will be no significant difference in infection rates between the two groups.

Why it matters

Potential benefit: If successful, this study could optimize antibiotic delivery methods during ankle surgeries, potentially reducing infection rates.

How similar studies have gone: While there is limited data on intraosseous administration of antibiotics in this context, similar studies have shown promise in other surgical settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Patient is undergoing total ankle arthroplasty.
* Patient is able to give informed consent to participate in the study. LAR consents will not be utilized for this study
* Age Range \>18

Exclusion Criteria

* Previous lower extremity surgery that in the opinion of the principal investigator or qualified research personnel precludes the participant from safely participating on the study.
* BMI \> 40.
* Contraindication to receiving vancomycin, cefepime, ancef, or other standard of care pre-operative antibiotic (allergy, medical issue, etc).
* Inability to administer the IO infusion.
* Patient refusal to participate.
* Uncontrolled Diabetes Mellitus type 1 or 2, defined as Hemoglobin A1C \>7.5.
* Immunocompromised or immunosuppressed patients (HIV, Hep C, end stage renal disease, dialysis, transplant, chemo/radiation treatment in last 6 months, medications).
* Vulnerable populations

Where it's running

  • Houston Methodist Hospital
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.